C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction

European Heart Journal

Volumn 30, Issue 10, 2009, Pages 1180-1186

  Ørn, Stein ^a,b   Manhenke, Cord ^a,b   Ueland, Thor ^c   Dams, Jan K ^c   Mollnes, Tom Eirik ^c   Edvardsen, Thor ^c   Aukrust, Pl ^c   Dickstein, Kenneth ^b  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Acute myocardial infarction; C reactive protein; Cardiac magnetic resonance; Inflammation; Interleukin 6; Primary percutaneous intervention; Remodelling; Terminal complement complex

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BLOOD VESSEL OCCLUSION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; DISEASE ASSOCIATION; FEMALE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; HUMAN; MALE; MICROCIRCULATION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ST SEGMENT ELEVATION;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; C-REACTIVE PROTEIN; COMPLEMENT MEMBRANE ATTACK COMPLEX; CORONARY CIRCULATION; ELECTROCARDIOGRAM PATTERN; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MAGNETIC RESONANCE IMAGING; MALE; MICROCIRCULATION; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; SAMPLE SIZE; STATISTICS, NONPARAMETRIC; STENTS; TIME FACTORS; TROPONIN T; VENTRICULAR REMODELING;

EID: 66249137776     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehp070     Document Type: Article

References (22)

1. Nian M, Lee P, Khaper N, Liu P. Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res 2004;94:1543-1553.
2. Anzai T, Yoshikawa T, Shiraki H, Asakura Y, Akaishi M, Mitamura H, Ogawa S. C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. Circulation 1997;96:778-784.
3. Gwechenberger M, Mendoza LH, Youker KA, Frangogiannis NG, Smith CW, Michael LH, Entman ML. Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions. Circulation 1999;99:546-551.
4. Suleiman M, Khatib R, Agmon Y, Mahamid R, Boulos M, Kapeliovich M, Levy Y, Beyar R, Markiewicz W, Hammerman H, Aronson D. Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction - predictive role of C-reactive protein. J Am Coll Cardiol 2006;47:962-968.
5. Ohlmann P, Jaquemin L, Morel O, El Behlgiti R, Faure A, Michotey MO, Beranger N, Roul G, Schneider F, Bareiss P, Monassier JP. Prognostic value of Creactive protein and cardiac troponin I in primary percutaneous interventions for ST-elevation myocardial infarction. Am Heart J 2006;152:116- 127.
6. Griselli M, Herbert J, Hutchinson WL, Taylor KM, Sohail M, Krausz T, Pepys MB. C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction. J Exp Med 1999;190:1733- 1740.
7. Ingkanisorn WP, Rhoads KL, Aletras AH, Kellman P, Arai AE. Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction. J Am Coll Cardiol 2004;43:2253- 2259.
8. Judd RM, Lugo-Olivieri CH, Arai M, Kondo T, Croisille P, Lima JAC, Mohan V, Becker LC, Zerhouni EA. Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation 1995;92:1902-1910.
9. Taylor AJ, Al-Saadi N, Abdel-Aty H, Schulz-Menger J, Messroghli DR, Friedrich MG. Detection of acutely impaired microvascular reperfusion after infarct angioplasty with magnetic resonance imaging. Circulation 2004;109: 2080-2085.
10. Wu KC, Zerhouni EA, Judd RM, Lugo-Olivieri CH, Barouch LA, Schulman SP, Blumenthal RS, Lima JA. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998;97:765-772.
11. Hombach V, Grebe O, Merkle N, Waldenmaier S, Höher M, Kochs M, Wöhrle J, Kestler HA. Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur Heart J 2005;26:549-557.
12. Gerber BL, Garot J, Bluemke DA, Wu KC, Lima JA. Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation 2002;106:1083-1089.
13. Mollnes TE, Lea T, Frøland SS, Harboe M. Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex. Scand J Immunol 1985;22:197-202.
14. Gottsauner-Wolf M, Zasmeta G, Hornykewycz S, Nikfardjam M, Stepan E, Wexberg P, Zorn G, Glogar D, Probst P, Maurer G, Huber K. Plasma levels of C-reactive protein after coronary stent implantation. Eur Heart J 2000;21:1152-1158.
15. Almagor M, Keren A, Banai S. Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease. Am Heart J 2003;145:248-253.
16. Haase J, Bayar R, Hackenbroch M, Störger H, Hofmann M, Schwartz CE, Reinemer H, Schwartz F, Ruef J, Sommer T. Relationship between size of myocardial infarctions assessed by delayed contrast-enhanced MRI after primary PCI, biochemical markers, and time to intervention. J Interv Cardiol 2004;17:367-373.
17. ørn S, Manhenke C, Anand I, Squire I, Nagel E, Edvardsen T, Dickstein K. Effect of left ventricular scar size, location and transmurality on left ventricular remodeling with healed myocardial infarction. Am J Cardiol 2007;99:1109-1114.
18. Damås JK, Waehre T, Yndestad A, Otterdal K, Hognestad A, Solum NO, Gullestad L, Frøland SS, Aukrust P. Interleukin-7-mediated inflammation in unstable angina: possible role of chemokines and platelets. Circulation 2003;107: 2670-2676.
19. Nijmeijer R, Krijnen PA, Assink J, Klaarenbeek MA, Lagrand WK, Veerhuis R, Visser CA, Meijer CJ, Niessen HW, Hack CE. C-reactive protein and complement depositions in human infarcted myocardium are more extensive in patients with reinfarction or upon treatment with reperfusion. Eur J Clin Invest 2004;34: 803-810.
20. Hoffmeister HM, Ehlers R, Büttcher E, Kazmaier S, Szabo S, Beyer ME, Steinmetz A, Seipel L. Comparison of C-reactive protein and terminal complement complex in patients with unstable angina pectoris versus stable angina pectoris. Am J Cardiol 2002;89:909-912.
21. Roes SD, Kelle S, Kaandorp TA, Kokocinski T, Poldermans D, Lamb HJ, Boersma E, van der Wall EE, Fleck E, de Roos A, Nagel E, Bax JJ. Comparison of myocardial infarct size assessed with contrast-enhanced magnetic resonance imaging and left ventricular function and volumes to predict mortality in patients with healed myocardial infarction. Am J Cardiol 2007;100:930-936.
22. Kim RJ, Choi KM, Judd RM. Assessment of myocardial viability by contrast enhancement. In: Higgins CB, de Roos A eds. Cardiovascular MRI and MRA. Philadelphia: Lippincott Williams and Wilkins; 2003. p.223-224.